Redview Capital
ROOM S239, 2/F, THE CAPITAL, 61-65 CHATHAM ROAD SOUTH, TSIM SHA TSUI, TSIM SHA TSUI, HONG KONG
Overview
Redview Capital is a private equity investment fund that focuses on traditional growth investment opportunities and the Chinese market. The company was founded in January 2016.
- Total investments
- 4
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 2
Investment portfolio
- MegaRobo
Participated · Series C · Jun 2022
MegaRobo Technologies builds automation solutions for life sciences R&D, offering products that range from benchtop workflow automation to fully automated platforms for complex, large-system workflows. Its workflow automation integrates AI software, analytical instruments, hardware and consumables into a single system. The company’s products are adopted in multiple countries and are used in applications such as antibody selection, cell line development and molecular screening. MegaRobo has collaborated with partners including CELLada on high-throughput organoid cultivation and Agilent Technologies on integrated automation for synthetic biology and biopharmaceutical R&D. Led by CEO Daniel Huang, the company plans to continue investing in R&D, increase capacity and pursue global expansion. The article reports a major financing event that strengthens the company’s ability to execute on those plans. MegaRobo is a Chinese high-tech startup that applies artificial intelligence and robotics to life sciences and other sectors. The company describes itself as operating at the intersection of AI, robotics and life‑science applications. According to a company statement reported in the article, MegaRobo has raised $65 million in a funding round. The round was led by Hong Kong‑listed pharma giant WuXi AppTec, and other named participants include Matrix Partners and Sinovation. No operating metrics, valuation, or detailed use-of-proceeds were disclosed in the article. Meiga Robotics builds automated robotics and AI solutions tailored to life‑science applications including new‑drug R&D, gene engineering, and clinical diagnostics. The company has deployed dozens of automated systems and served nearly 100 life‑science customers, driving large efficiency gains: operation precision and repeatability improved by two orders of magnitude, throughput rose up to 100x in some workflows, and certain automated diagnostic workstations enabled daily nucleic‑acid testing capacity of 260,000 samples. Standard product offerings include fully automated reagent filling and dispensing systems (processing up to 900 ep tubes per hour, ~4 seconds per tube). During COVID‑19, Meiga’s automated nucleic‑acid workstations delivered ~20x throughput versus manual methods while reducing frontline infection risk. The company in 2024 launched the Meiga “Kunpeng Laboratory” sub‑brand to integrate robotics, AI and biology, and it has internally developed automated platforms for mammalian cell culture, phenotypic detection, gene editing, and high‑throughput drug screening. Meiga plans to expand its core business and continue R&D and construction of the Kunpeng Laboratory to strengthen its competitive moat in life‑science automation. The company was founded in June 2016 and is based in Beijing.
- Hive Box
Participated · Equity · Jan 2021
HiveBox operates a last‑mile logistics parcel‑locker network and is focused on expanding and deepening its terminal network layout. The company said the financing is intended to help it quickly capture advantageous last‑mile locations, provide higher‑quality service and experience, and improve terminal efficiency. HiveBox is held through HiveBox Holdings Limited (丰巢开曼), in which SF Holding (顺丰控股) participates via its overseas wholly owned subsidiary Liangyue Co., Ltd. The company completed an equity financing that issued new ordinary shares and created a pool of shares reserved for employee equity incentives. Existing shareholders did not participate in the new share subscription, resulting in dilution of SF Holding’s stake. Ikai Capital (易凯资本) served as exclusive financial advisor on the transaction.
- Geek+
Participated · Series C · Jun 2020
Geek+ produces a variety of warehouse robotics systems, centered on a Kiva-style wheeled robot that carts inventory shelves. The company emphasizes three technology pillars—robotics, systems, and algorithms—and offers a full product line. Geek+ cites global expansion as a primary motivator and has announced deployments in North and South America as well as partner deals in Europe. The firm reported $150 million in revenue last year and had $300 million in orders. Geek+ is led by founder and CEO Yong Zheng, who highlights first-mover advantages and improvements in R&D efficiency and cost. The company continues to expand amid strong investor interest in warehouse automation. Geek+ develops autonomous mobile robots and end-to-end robotics solutions for warehouse fulfillment and logistics, often compared to Amazon’s Kiva system. The company sells robots and is ramping a robot-as-a-service monetization model to drive recurring revenue. Geek+ has deployed more than 10,000 robots worldwide, serving about 300 customers across over 20 countries. It is pursuing international expansion, including a Conveyco partnership to distribute robots in North America and leadership hires for Americas operations. Financially, Geek+ closed a Series C of over $200 million and has raised nearly $390 million in total capital to date. The company said it will continue developing tailored robotics solutions and expanding partnerships and deployments. Geek+ is a Beijing-based robotics startup that builds unmanned robots for warehouses and logistics operations. Its product suite includes cargo-to-man picking systems, sorting and movement systems, and unmanned forklifts. The company says it has delivered more than 5,000 robots across roughly 100 warehouse projects in China, Hong Kong, Taiwan, Japan, Australia, Singapore, Europe, and the United States, with customers such as Alibaba’s Tmall and VIP.com. Geek+ projects to grow its business by more than five-fold this year and plans to invest the new funding in product development, sales, and customer service. The startup has raised around $217 million since being founded in 2015 and claims this latest round is the largest-ever funding round for a logistics robotics startup. Management says it will focus on integrating AI, big data and robotics to optimize supply chains and expand internationally. Geek+ develops one-stop intelligent logistics robot solutions powered by AI and robotics, covering storage, order picking, material handling and parcel sorting. Its systems perform functions such as order division and consolidation, intelligent inventory replenishment, returns handling, SKU correlation analysis, route optimization, collision and congestion control, and dynamic shelf optimization. Customers include e-commerce platforms, third-party logistics providers, express delivery companies, offline retailers and manufacturers across apparel, pharmaceuticals, automotive and electronics. The company has established strategic partnerships to co-develop customized AI and robotic solutions and has delivered nearly 1,000 robot units to over 20 customers, including Tmall, VIPShop and Suning. Geek+ plans to use its new financing to upgrade its logistics robotics products, expand product offerings to more applications, accelerate geographical expansion and industry coverage, and begin exploring overseas markets through multiple channels. The company was founded in early 2015 and is based in Beijing.
- Kateeva
Participated · Series E · May 2016
Kateeva develops precision deposition equipment for OLED manufacturers. Its core product is the YIELDjet platform, which uses inkjet printing to deposit coatings for mass production of flexible and large-size OLED displays and other products. The company plans to accelerate product development, strengthen customer-satisfaction infrastructure in Asia, and support continued R&D with the new funding. Kateeva maintains operations in Korea, China, Japan and Taiwan and is headquartered in Newark, CA. It has raised $200M to date and recently closed an $88M Series E. Founded in 2008 and led by Chairman and CEO Alain Harrus, Ph.D., the company focuses on scaling manufacturing tools for advanced electronics. Kateeva develops the YIELDjet™ precision deposition platform that uses inkjet printing to mass-produce flexible and large-size OLED panels. The company is building production systems at its Menlo Park facility to fulfill early orders. It intends to use the new funds to support its manufacturing strategy and to expand its global sales and support infrastructure. Kateeva has raised more than $110m in total funding to date. The company was founded in 2008 and is led by CEO Alain Harrus.